MSX2 and breast cancer: Notably, MSX2 is also abnormally expressed in a variety of carcinoma cells, including adenocarcinoma [12], breast cancer [13], and ovarian endometrioid carcinoma [14], in which MSX2 expression is highly correlated with cell invasion levels.